Cellectis S.A. current report, Q1 FY2023

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on March 6, 2023. The filing serves to distribute a press release dated March 6, 2023, to U.S. investors. The registrant files annual reports under Form 20-F.

Financial Metrics

The provided filing text does not contain specific financial data. It acts as a cover document for an external press release (Exhibit 99.1) and does not list revenue, profit, cash flow, margins, debt, or liquidity figures.

Material Changes

The filing text does not provide details on material changes versus prior periods. The content is limited to the submission of a press release, the specifics of which are not included in the provided text.

Guidance, Outlook, and Risks

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided text. The document only confirms the submission of a press release by CEO André Choulika.

Key Facts for Investor Verification

  • Verify the content of the attached Press Release (Exhibit 99.1) for the actual announcement details.
  • Confirm the date of the press release is March 6, 2023.
  • Note that this filing does not include audited or unaudited financial statements.
  • Identify the CEO as André Choulika, who authorized the report.